Lymphocyte populations in rheumatoid arthritis
Arthritis and Rheumatism
|July 1, 1976
Summary
Rheumatoid arthritis (RA) patients show a reduced number of lymphocytes that respond to concanavalin A (Con A). This specific lymphocyte subpopulation is critical for immune response in RA.
Area of Science:
- Immunology
- Rheumatology
- Cellular Biology
Background:
- Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic inflammation.
- Lymphocyte function plays a crucial role in the pathogenesis of autoimmune diseases like RA.
- Understanding specific lymphocyte subpopulations involved in RA is essential for developing targeted therapies.
Purpose of the Study:
- To investigate the in vitro lymphocyte responses to phytohemagglutinin (PHA) and concanavalin A (Con A) in patients with RA.
- To identify potential alterations in lymphocyte subpopulations in RA patients compared to healthy controls.
- To explore the functional significance of Con A-responsive lymphocytes in the context of RA.
Main Methods:
- Simultaneous determination of in vitro lymphocyte responses to PHA and Con A in 28 RA patients and 27 healthy controls.
- Utilizing bromodeoxyuridine (BUdR) to selectively eliminate PHA-responsive lymphocytes.
- Analyzing the relative response to Con A in remaining lymphocyte populations.
Main Results:
- Lymphocytes from RA patients exhibited a significantly lower response to Con A compared to PHA.
- Selective elimination of PHA-responsive cells revealed a reduced relative increase in Con A response in RA lymphocytes.
- This indicates a specific reduction in the Con A-responsive lymphocyte subpopulation in RA.
Conclusions:
- RA is associated with a relative deficiency in a lymphocyte subpopulation that primarily responds to Con A.
- This finding suggests a potential role for Con A-responsive lymphocytes in the immune dysregulation observed in RA.
- Further research into this specific lymphocyte subset may offer new therapeutic targets for RA.
Related Concept Videos
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...